Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing
Professor Alexandre Erler had the honor to publish a new article with the other co-authors in Stem Cell Reports. Congrats to Alex! For more information on Alex’s article, please click here.
Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies.